Xian Lin

Title: Innovations in Avian Influenza Treatment by Xian Lin

Introduction

Xian Lin is a notable inventor based in Hubei, China. He has made significant contributions to the field of medicine, particularly in the treatment and prevention of avian influenza virus infections. His innovative work has the potential to impact animal health positively.

Latest Patents

Xian Lin holds a patent for a compound bacterium preparation designed for treating or preventing avian influenza virus infection. This invention reveals that ATCC Accession No. 25527 can effectively treat animals infected by the H7N9 strain. When compounded with ATCC Accession No. 25526, the therapeutic effect is enhanced. The compound preparation is capable of regulating the body's immune response, significantly improving weight loss and lung tissue injury caused by H7N9 influenza virus infection. Furthermore, it notably increases the survival rate of mice infected by H7N9 influenza virus. The probiotic preparation provided by this invention demonstrates remarkable efficacy in resisting H7N9 influenza virus infection and can be effectively utilized for preventing and treating avian influenza virus infections.

Career Highlights

Xian Lin is affiliated with Huazhong Agricultural University, where he conducts research and develops innovative solutions for animal health issues. His work is characterized by a commitment to advancing medical treatments that can benefit both animals and, by extension, human health.

Collaborations

Xian Lin collaborates with esteemed colleagues, including Meilin Jin and Qiang Zhang. Their combined expertise contributes to the advancement of research in the field of avian influenza treatment.

Conclusion

Xian Lin's innovative work in developing a compound bacterium preparation for avian influenza treatment showcases his dedication to improving animal health. His contributions are vital in the ongoing fight against viral infections in animals, highlighting the importance of research and innovation in this field.